Recurrent ovarian cancer can be re-operation

-- Health reported the recurrence of ovarian cancer surgery and chemotherapy again whether there has been significant controversy. Xijing Hospital, Fourth Military Medical University XIN Xiao-Yan, director of obstetrics and gynecology professor, recently admitted the past 10 years, 38 cases of recurrent epithelial ovarian cancer clinical data were analyzed retrospectively after that, recurrent ovarian cancer to surgery and chemotherapy can further improve The survival rate of patients. Primary ovarian cancer, 60.0% and 90.0% for the epithelial carcinoma, the initial clinical surgery after chemotherapy to cure, but there is still 85.0 percent of cases in the near future and long-term relapse. This 38 cases of recurrent ovarian cancer, 20 patients received tumor recurrence again laparotomy cytoreductive surgery, nine cases due to fear of surgery and the use of chemotherapy alone, the other nine cases of the use of traditional Chinese medicine or give up treatment. The results showed that 20 cases of surgery again after two to five-year survival rates were 69.8% and 52.4%, 42.7% and 26.4%; nine cases received chemotherapy only 2 to 5-year survival rates were 68.9% and 13.8%, 8.7% And 6.9 percent, to surgery and chemotherapy alone 5-year survival rates were significantly different (P <0.01);>